FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074365 [Registered on: 25/09/2024] Trial Registered Prospectively
Last Modified On: 24/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical Study To Evaluate The Shodhan Effect Of Gandirikadi Tailam Application In The Management Of Dushta Vrana(Infected Wound) 
Scientific Title of Study   A Randomized Controlled Clinical Trial To Evaluate The Shodhan Effect Of Gandirikadi Tailam Application In The Management Of Dushta Vrana. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Payal Gajanan Gaddamwar 
Designation  PG Scholar MS Shalyatantra 
Affiliation  Mes Ayurved Mahavidyalaya 
Address  Second floor,Shalyatantra department ,Pg section,Mes Ayurved Mahavidyalaya,Ghanekunt Lote,Khed,Ratnagiri

Ratnagiri
MAHARASHTRA
415722
India 
Phone  8329008455  
Fax    
Email  payal.gaddamwar001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Yogesh Borse 
Designation  HOD & Professor MS Shalyatantra 
Affiliation  Mes Ayurved Mahavidyalaya 
Address  Second floor,Shalyatantra department ,Pg section,Mes Ayurved Mahavidyalaya,Ghanekunt Lote,Khed,Ratnagiri

Ratnagiri
MAHARASHTRA
415722
India 
Phone  8329008455  
Fax    
Email  dryogeshborase@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Payal Gajanan Gaddamwar 
Designation  PG Scholar MS Shalyatantra 
Affiliation  Mes Ayurved Mahavidyalaya 
Address  Second floor,Shalyatantra department ,Pg section,Mes Ayurved Mahavidyalaya,Ghanekunt Lote,Khed,Ratnagiri

Ratnagiri
MAHARASHTRA
415722
India 
Phone  8999203043  
Fax    
Email  payal.gaddamwar001@gmail.com  
 
Source of Monetary or Material Support  
Mes Ayurved Mahavidyalaya & attached Parshuram Hospital & Research center,Ghanekunt Lote ,khed,Ratnagiri,Maharashtra,india - 415722 
 
Primary Sponsor  
Name  Dr Payal Gajanan Gaddamwar 
Address  Second floor,Shalyatantra department ,Pg section,Mes Ayurved Mahavidyalaya,Ghanekunt Lote,Khed,Ratnagiri 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Payal Gajanan Gaddamwar  Parshuram Hospital and Research center  Shalyatantra OPD,Ghanekhunt lote khed Ratnagiri
Ratnagiri
MAHARASHTRA 
8999203043

payal.gaddamwar001@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MES Ayurved Mahavidyalaya Ethics committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L089||Local infection of the skin and subcutaneous tissue, unspecified. Ayurveda Condition: DUSHTAVRANAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Eusol with Betadinelocal application over infected wound once a day for 12 days period
2Intervention ArmDrugClassical(1) Medicine Name: Gandirikadi tailam, Reference: Chakradatta 50th chapter ,160th shloka., Route: Topical, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 12 Days, anupAna/sahapAna: No, Additional Information: --dressing with Gandirikadi tailam will be done for 12 days in infected wound patient.
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1)Patient having complaints of infected chronic wound,Pus discharge through wound ,itching,Pain,Foul smell,Slough,Redness,Swelling
2)wound size up to 10 cm
3)Diabetic patient only those who are on treatment and maintaining their BSL
3)Patient who are ready to give written consent only will be selected  
 
ExclusionCriteria 
Details  1)Patient having Malignant ulcer,Tubercular ulcer,Gangrenous ulcer and Osteomylitis will be excluded
2)Patient who are not ready to give written consent
3)Uncontrolled diabetic patient
4) AIDS and HIV positive patients 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To study the shodhan effect of Gandirikadi tailam application in the management of Dushtavrana .
(Primary outcome will be assessed on the basis of certain objective and subjective parameters such as pain discharge tenderness floor and granulation tissue, malodour, size of wound results will be drawn with scoring system) 
12 days study
with baseline screening on 0th day.
Follow-up on 4th,8th,12th day 
 
Secondary Outcome  
Outcome  TimePoints 
1)To study etiopathogenesis of Dushta vrana .
2)To study the literature of Gandirikadi tailam.
data related all the drugs involved will be collected from different books & available ayurvedic literature to understand the action of drug & the disease etiopathogenesis 
12 days study with
Follow-up- on 4th,8th,12th day
(overall study duration 18 month) 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Title :- Randomized controlled clinical trial to evaluate the Shodhan effect of Gandirikadi tailam application in the management of Dushtavrana (infected wound).

Null Hypothesis :- Gandirikadi tailam application is not significantly effective in the management of Dushtavrana (infected wound).

Alternative hypothesis :- Gandirikadi tailam application is significantly effective in the management of Dushtavrana (infected wound).

Study design :- Simple Randomized Controlled Clinical Trial.


Inclusive criteria :-

1) Age - Patient age between 18 to 70 years old.

2) Patient having complaints of infected chronic wound , Pus discharge through wound ,Itching , Pain ,Foul smell , slough ,Redness, Swelling.

3) Wound size up to 10 cm.

4) Diabetic patients only those who are on treatment and maintaining their BSL.

5) Patients who are ready to give written consent only will be selected.



Exclusive criteria :-

1) Patient having Malignant ulcer, Tubercular ulcer ,Gangrenous ulcer and Osteomylitis will be excluded. 

2) Patient who are not ready to give written consent .

3) Uncontrolled Diabetic patient.

4) AIDS and HIV positive patients.



Sample size :- Total 40 (20 for each group)


Patients coming in OPD and IPD of Shalyatantra department of our hospital with complaints of Dushtavrana (infected wound). Simple Randomized Sampling (Lottery Method ).


Group A:- Gandirikadi Tailam

Group B :- Eusol with Betadine

Total duration of Drug administration is 12 days ( daily dressing with gauze soaked in Gandirikadi tailam in Group A and Eusol with betadine in Group B will be done for 12 days or till appearance of healthy wound). the mode of drug administration is local application.

Follow up :- Baseline screening will be done on 0th day and follow up will be done on 4th 8th and 12th day.

Result :- Result will be drawn as per assessment criteria and statistical analysis.

 
Close